Back

Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Valvular heart disease and infective endocarditis e-posters Aortic Valve Stenosis ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mrs Magdalena Kopytek

St. John Paul II Hospital, Krakow (Poland)

130 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis
Doctor N. Ngiam (Singapore, SG)
Abstract Slides
Presentation thumbnail
Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.
Doctor Z. Cheng (Chengdu, CN)
Abstract Slides
Presentation thumbnail
Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience
Doctor S. Mahmood (Detroit, US)
Abstract Slides
Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI
Doctor V. Jimenez Franco (San Pedro Garza Garcia, MX)
Abstract Slides

Access the full session

Session thumbnail
Valvular heart disease and infective endocarditis e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources